Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes
Open Access
- 25 February 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (15) , 20124-20139
Abstract
Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypesKeywords
This publication has 59 references indexed in Scilit:
- Tissue Biomarkers for Prognosis of Prostate Cancer: A Systematic Review and Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2014
- Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discoveryCell Cycle, 2013
- Exosomes as Biomarker Treasure Chests for Prostate CancerEuropean Urology, 2011
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcomeLaboratory Investigation, 2009
- The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass SpectraMolecular & Cellular Proteomics, 2007
- Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinomaProstate Cancer and Prostatic Diseases, 2006
- Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.2002
- Natriuretic Peptides Suppress Vascular Endothelial Cell Growth Factor Signaling to Angiogenesis*Endocrinology, 2001
- Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epitheliumBreast Cancer Research, 2000
- The Motility-Associated Proteins GAP-43, MARCKS, and CAP-23 Share Unique Targeting and Surface Activity-Inducing PropertiesExperimental Cell Research, 1997